"Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis"
[] Source:
However, people who go on Semaglutide or Tirzepatide to treat their type 2 diabetes tend to lose weight not a bad side effect for most of us
Several drugs are currently in advanced clinical trials: Phase III Clinical Trials: IBI362 (Innovent/Eli Lilly), CagriSema (Novo Nordisk), Retatrutide (Eli Lilly), and Survodutide (Boehringer Ingelheim)
From my own observation and discussions with clinicians using MOTS-C with patients, subjective improvements in endurance, recovery, and body composition ARE commonly reported
Some patients benefit from structured programs combining nutrition, exercise, and behavioral support tailored to Type 1 physiology